Institute of Pathology

Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy (2024) Saalfeld FC, Möller J, Christopoulos P, Wenzel C, Rasokat A, Wang XA, Vathiotis I, et al. Journal article Corrigendum to “Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations” [Eur J Cancer 207 (2024) 114158](S0959804924008141)(10.1016/j.ejca.2024.114158) (2024) Kron A, Scheffler M, Wiesweg M, Hummel HD, Kulhavy J, Gatteloehner S, Kollmeier J, et al. Journal article, Erratum Development of a novel immunocompetent murine tumor model for urothelial carcinoma using in vivo electroporation (2024) Soleder S, Gengenbacher N, Mogler C, Eckstein M, Runge A, Kriegmair MC, Augustin HG Journal article Architectural crypt distortions in ulcerative colitis: Time for reappraisal (2024) Rubio CA, Lang-Schwarz C, Vieth M Journal article, Review article Malignant Bone-Forming Neoplasm With NIPBL::BEND2 Fusion (2024) Dashti NK, Matcuk G, Agaimy A, Saoud C, Antonescu CR Journal article Prognostic factors in clear cell sarcoma: an analysis of soft tissue sarcoma in 43 cases (2024) Grothues J, Hardes J, Agaimy A, Collaud S, Podleska LE, Farzalyev F, Engel NM, et al. Journal article TFE3-rearranged nonmelanotic renal PEComa: a case series expanding their phenotypic and fusion landscape (2024) Agaimy A, Acosta AM, Cheng L, Collins K, Fridman E, Schubart C, Williamson SR, et al. Journal article Benchmarking whole exome sequencing in the German network for personalized medicine (2024) Menzel M, Martis-Thiele M, Goldschmid H, Ott A, Romanovsky E, Siemanowski-Hrach J, Seillier L, et al. Journal article The TRPC5 receptor as pharmacological target for pain and metabolic disease (2024) Khare P, Chand J, Ptakova A, Liguori R, Ferrazzi F, Bishnoi M, Vlachova V, Zimmermann K Journal article, Review article Prognosis prediction with the IHC3 score in patients with node-negative, hormone receptor-positive, HER2-negative early breast cancer (2024) Seitz K, Goossens C, Hübner H, Gaß P, Uhrig S, Heindl F, Emons J, et al. Journal article